Clinical trial / 2018
Dietary fibers selectively promoted gut bacteria producing short-chain fatty acids, improving HbA1c levels in patients with type 2 diabetes.
A randomized clinical study of specifically designed isoenergetic diets paired with fecal shotgun metagenomics evaluated the effect of dietary fibers in patients with type 2 diabetes mellitus. Dietary fibers selectively promoted a specific group of short-chain fatty acid (SCFA)-producing strains while diminishing or leaving unchanged most other potential producers. Greater diversity and abundance of these fiber-promoted SCFA producers led to greater improvements in hemoglobin A1c levels, partly through increased glucagon-like peptide-1 production, and diminished bacteria producing detrimental compounds like indole and hydrogen sulfide.
- Study type
- Randomized clinical study
- Who was studied
- Patients with type 2 diabetes mellitus (sample size not stated)
- What was measured
- Gut microbiota composition, SCFA producers, hemoglobin A1c, and glucagon-like peptide-1
THE PAPER
Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes.
Zhao L, Zhang F, Ding X, Wu G, Lam YY, Wang X, Fu H, Xue X, Lu C, Ma J, Yu L, Xu C, Ren Z, Xu Y, Xu S, Shen H, Zhu X, Shi Y, Shen Q, Dong W, Liu R, Ling Y, Zeng Y, Wang X, Zhang Q, Wang J, Wang L, Wu Y, Zeng B, Wei H, Zhang M, Peng Y, Zhang C. Science, 2018.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.